Monograph Details
|
|
Urogenital System
> Miscellaneous urogenital disorders
|
|
POLYCITRA-K |
| Manufacturer |
|
Ortho-McNeil Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Urinary alkalinizer. |
| Generic Name |
|
Potassium citrate 1100mg, citric acid 334mg; (equiv. to bicarbonate 10mEq); per 5mL; contains potassium 2mEq/mL; sugar-free; soln. |
| Also |
• POLYCITRA
• POLYCITRA-K CRYSTALS
• POLYCITRA-LC
|
| Indications |
|
Urinary alkalinization. |
| Children |
|
5–15 mL diluted in 6 oz water 4 times a day after meals and at bedtime. |
| Adults |
|
15 mL diluted in 6 oz water 4 times a day after meals and at bedtime. |
| Contraindications |
|
Renal or adrenal insufficiency. Myocardial damage. Anuria. Hyperkalemia. Dehydration. Heat cramps. Adynamia episodica hereditaria. |
| Precautions |
|
Electrolyte restrictions. Cardiac failure. Hypertension. Edema. Monitor serum electrolytes. Urine pH 6.5–7.4 occurs with doses of 10–15 mL; urine pH 7–7.6 with doses of 15–20 mL. Toxemia of pregnancy. |
| Interactions |
|
Hyperkalemia with ACE inhibitors, triamterene, spironolactone, amiloride and potassium supplements. Toxicity with digitalis. |
| Adverse Reactions |
|
GI distress, laxation, alkalosis, hypocalcemia, weakness, confusion, paresthesias. |
| How Supplied |
Plain, LC, K—pt
Crystals—100 packets |
|
|
|
|
